Trial Profile
An Open, Non-randomized Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma on Tear Film Thickness
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2017
Price :
$35
*
At a glance
- Drugs Tafluprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- 22 Aug 2017 Status changed from recruiting to completed.
- 05 Jul 2017 New trial record